Medtech lobbyists praised Congress’ last-minute passage of the Medical Device User Fee Amendments (MDUFA), which will provide the Food and Drug Administration between $1.78 billion and $1.9 billion over the next five years to fund its review of medical devices.

Groups including AdvaMed, the Medical Imaging & Technology Alliance and the Medical Device Manufacturers Association said the agreement would support innovation in healthcare and patient access to new technologies, although several reforms were pulled from the bill in an effort to pass it on time.